Toth Financial Advisory’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
Toth Financial Advisory's VYGR Position: Q3 2026 in Review
Toth Financial Advisory sold out of Voyager Therapeutics (VYGR) in Q3 2026, closing a stake of 250 shares — an estimated $875 sold.
Toth Financial Advisory first reported a position in VYGR in Q1 2026 and held it in 2 quarters. The position peaked at $965 in Q1 2026. 2 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.
- Toth Financial Advisory reported no remaining Voyager Therapeutics position as of Q3 2026 after selling out during the quarter.
- Toth Financial Advisory sold 250 Voyager Therapeutics shares in Q3 2026, an estimated $875.
- Toth Financial Advisory first reported a position in Voyager Therapeutics in Q1 2026 and held it in 2 quarters.
- Toth Financial Advisory's Voyager Therapeutics position peaked at $965 in Q1 2026.
- 2 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.
Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.